Organ-on-a-chip in 2026: overview
Organ-on-a-chip systems combine living cells with microengineered environments that control fluid flow and other conditions to model human tissue functions. They offer researchers a way to study disease and drug responses in human-relevant settings, complementing conventional cell cultures and animal models. The challenge is to reproduce complex tissue behavior reliably while making devices and results consistent enough for use across laboratories and in drug development.
Recent work is pushing beyond flat, rigid chip designs toward more realistic structures and readouts. In September 2026, University of Calgary researchers reported a cleanroom-free membrane-integrated platform for forming intestinal tissue, while a September study from Polytechnic University of Turin and Ecole Polytechnique Federale de Lausanne explored tomographic printing for biomimetic 3D chips. Organ-on-chip publications grew 29.8%, and organoid-integrated platforms grew 82.8%; Bruker’s August 2026 majority investment in MIMETAS also points to closer integration of tissue models with analytical and imaging tools.
- 1Build beyond flat channels: Cleanroom-free fabrication and tomographic printing point toward more accessible devices with three-dimensional tissue structures.
- 2Add live readouts: Sensor integration and real-time monitoring are emerging as ways to observe cellular responses without interrupting chip experiments.
- 3Connect models to decisions: Drug testing and precision medicine are prominent use cases, but broader adoption depends on demonstrating that chip results translate to human outcomes.
Top organizations working on organ-on-a-chip
Ranked by Linknovate activity score · last 24 monthsThe activity score adds up the relevance of every patent, publication, grant and news item linking an organization to organ-on-a-chip. Showing 7 of 1,707 organizations.
| # | Organization | Approach | Signals (24 mo) | Momentum | Why it matters |
|---|---|---|---|---|---|
| 1 | 
U.S. Food and Drug Administration
Other · United States |
General | PUB 26 · NEWS 234 | -22% | Recently, FDA-CDER collaborated on a cross-platform evaluation of microphysiological systems for drug-induced liver injury, informing assessment of these models for regulatory use. |
| 2 | 
CN Bio Innovations Ltd
Startup · United Kingdom |
Interconnected multi-organ systems | PUB 5 · NEWS 83 | -46% | Recently, CN Bio received an Innovate UK grant with partners to develop organ-on-a-chip approaches for pharmacokinetic studies that could reduce animal use. Its PhysioMimix platform supports human-relevant drug testing. |
| 3 | 1U
12579Southeast University
Research |
Scaffold-based 3D tissue chips | PUB 65 | +60% | Recently, researchers developed a lymphatic organ-on-a-chip to investigate how flow-responsive lymphatic endothelial signals influence bone-forming cells in jawbone regeneration. |
| 4 | 
Harvard University
Research · United States |
Membrane-based barrier chips | PAT 1 · PUB 71 NEWS 30 |
+55% | Harvard researchers study tissue-barrier chips, including models of the blood-brain barrier, gut, lung and kidney, and develop fabrication methods for organ-on-chip devices. |
| 5 | 
Tissuse Gmbh
Startup · Germany |
Interconnected multi-organ systems | PUB 11 · NEWS 56 | -74% | TissUse develops its Multi-Organ-Chip platform to connect human tissue models for preclinical testing of drug safety and efficacy. |
| 6 | 
Mimetas B.V
Corporate · Netherlands |
Scaffold-based 3D tissue chips | PUB 8 · GRANTS 2 NEWS 56 |
-62% | Recently, Bruker took a majority stake in MIMETAS, bringing its organ-on-a-chip and human tissue models together with Bruker’s analytical and imaging technologies for drug discovery. |
| 7 | 
U.S. National Institutes of Health
Research · United Kingdom |
General | PUB 9 · NEWS 118 | -16% | NIH supports microphysiological systems research and alternatives to animal testing through biomedical research programs, including work on human-relevant tissue models. |
| 8 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 9 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
| 10 | ··Hidden organizationCompany | Approach | PAT 00 · PUB 00 GRANTS 0 · NEWS 00 | +00% | Available to registered users. |
Startups to watch and leading research centers
Startups to watch 44 total
Hesperos Inc.United StatesRecently, Hesperos researchers used Human-on-a-Chip models to study cannabidiol exposure across distinct organ-on-chip systems. Its platform links human tissue models for disease studies and drug testing.
Emulate Inc.United StatesEmulate develops human tissue chips that reproduce organ-level functions for drug safety and disease research, including barrier models used to study human responses.
SynvivoUnited StatesSynVivo develops 3D microfluidic tissue models that combine co-cultured cells with endothelial-lined channels to study processes such as inflammation.- ··Hidden startupCountryAvailable to registered users, with funding and founding year.
- ··Hidden startupCountryAvailable to registered users, with funding and founding year.
Leading research institutions 1,409 total
- 1U12579Southeast UniversityRecently, researchers developed a lymphatic organ-on-a-chip to investigate how flow-responsive lymphatic endothelial signals influence bone-forming cells in jawbone regeneration.
- Harvard UniversityUnited StatesHarvard researchers study tissue-barrier chips, including models of the blood-brain barrier, gut, lung and kidney, and develop fabrication methods for organ-on-chip devices.
- U.S. National Institutes of HealthUnited KingdomNIH supports microphysiological systems research and alternatives to animal testing through biomedical research programs, including work on human-relevant tissue models.
- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
- ··Hidden research institutionCountryAvailable to registered users, with their key researchers.
Where organ-on-a-chip innovation happens
Share of documents with at least one organization from each country.
Open the interactive map with all 1,707 organizationsMain technical approaches
Last 24 months| Approach | What it is | Documents | Leading organizations |
|---|---|---|---|
| Membrane-based barrier chips | Membranes separate cell layers to model tissue barriers, but can constrain realistic cell-to-cell contact and three-dimensional structure. | 459 |
12579Southeast University, University of Virginia, Emulate Inc. |
| Scaffold-based 3D tissue chips | Scaffolds support tissue-like three-dimensional structures, but material choice and fabrication can affect cell behavior and reproducibility. | 633 |
12579Southeast University, Chinese University of Hong Kong, University of Toronto |
| Organoid-integrated platforms | These platforms combine self-organizing organoids with microfluidic control, but organoid variability can make results harder to standardize. | 410 |
U.S. Food and Drug Administration, Harvard University, Chinese Academy of Sciences CAS |
| Interconnected multi-organ systems | Linked tissue models can represent interactions across organs, but balancing flow, scale and shared culture conditions is technically demanding. | 309 |
Tissuse Gmbh, CN Bio Innovations Ltd, U.S. Food and Drug Administration |
| Sensor-integrated platforms | Embedded sensors monitor tissue conditions in real time, but integration can add complexity and affect chip design or cell environments. | 229 |
University of Rochester, Hesperos Inc., University of Minho |
Emerging trends
Last 12 months vs previous 36 monthsTerms whose frequency in the last 12 months grew the most compared with the previous 36 months.
Funding and investment
Recent funding rounds
Since 2020, recorded grants total $340,592,985 across 241 awards. These grant figures are separate from the broader funding-round total, which also includes corporate expansions.
Patent landscape
Top patent holders · last 24 monthsRecent developments
Latest news, duplicates removed- Sep 2026From nanoscale magnetic signals to metabolic and thermal changes, researchers are exploring how quantum sensing could give organ-on-a-chip systems a closer view of biology as it unfolds. Paper: Integration of quantum…AZoNano.com - Nanotechnology News Feed
- Sep 2026Organoids and organs-on-chips (OoCs) have emerged as powerful tools to replicate human tissues in the lab, but recreating the body’s complex mechanical environment remains a major challenge. A new review led by…Scientific Inquirer
- Sep 2026Cancer’s spread to distant organs can now be studied using lab-grown bone, lung, and blood vessel tissues. Cancer becomes far more dangerous when it stops being confined to one place. Most cancer deaths are not caused…SciTechDaily
- Aug 2026A comprehensive look at how microfluidic devices are reshaping biomedical research — and where they still fall short. For decades, the path from laboratory discovery to approved drug has been paved with animal…Science on Medium
- Month 20XXHidden developmentAvailable to registered users with alerts enabled.
Frequently asked questions about organ-on-a-chip
What companies are working on organ-on-a-chip?
Examples include CN Bio Innovations Ltd, Emulate Inc., Hesperos Inc., Tissuse Gmbh and Mimetas B.V. CN Bio develops the PhysioMimix platform, while Emulate develops human tissue chips. Hesperos and TissUse focus on linked tissue models, and MIMETAS develops organ-on-a-chip and human tissue models. The field also includes research organizations and public agencies.
Which organ-on-a-chip startups are active in 2026?
CN Bio Innovations Ltd, Hesperos Inc., Emulate Inc. and Synvivo are among the startups active in organ-on-a-chip. CN Bio’s PhysioMimix platform supports human-relevant drug testing; Hesperos links human tissue models; Emulate develops human tissue chips; and Synvivo builds 3D microfluidic tissue models. These examples span multi-organ, barrier and scaffold-based approaches.
Which universities and research centers lead organ-on-a-chip research?
Harvard University, Southeast University, Chinese Academy of Sciences CAS, the University of Toronto and the Chinese University of Hong Kong are active research organizations. Harvard works on tissue-barrier chips, and Southeast University develops scaffold-based models. Recent work also includes a University of Calgary cleanroom-free intestinal platform reported in September 2026.
How much funding has organ-on-a-chip received?
Organ-on-a-chip has $340,592,985 in recorded grants across 241 awards since 2020. This grant total is distinct from the broader funding-round figure, which can include corporate expansions not specifically tied to organ-on-a-chip research. CN Bio Innovations Ltd also received an Innovate UK grant announced in August 2026 for pharmacokinetic studies intended to reduce animal use.
Who holds the most organ-on-a-chip patents?
Huawei leads the listed patent holders with 9 patents. Darwin Precisions Corporation and CHIPSEA TECHNOLOGIES SHENZHEN Corporation each have 8, followed by Samsung, The Trustees Of The University Of Pannsylvania and Mitsubishi Materials with 5 each. These figures describe patent-holder counts in the available data, not the full patent portfolios of those organizations.
Is organ-on-a-chip patent activity growing?
Patent activity is lower in the latest window: 236 patents were recorded over the 24-month window, and the annual patent count fell from 160 in 2024 to 139 in 2025. Publication activity moved in the opposite direction, with 1,541 publications last year and growth of 29.8%. This contrast suggests research is expanding faster than patenting.
What are the latest developments in organ-on-a-chip?
Recent developments include a cleanroom-free membrane-integrated intestinal platform from the University of Calgary in September 2026 and tomographic printing for biomimetic 3D chips, reported by Polytechnic University of Turin and Ecole Polytechnique Federale de Lausanne that month. In August 2026, Bruker announced a majority investment in MIMETAS, combining its tissue models with Bruker’s analytical and imaging technologies.
What are the main approaches in organ-on-a-chip, and how do they differ?
The main approaches are membrane-based barrier chips, scaffold-based 3D tissue chips, organoid-integrated platforms, interconnected multi-organ systems and sensor-integrated platforms. They differ in how they build tissue structure, connect organs or measure cell behavior. Membranes model separated tissue layers; scaffolds and organoids support 3D structures; multi-organ systems link models; and sensors monitor conditions.
Which countries lead organ-on-a-chip?
The United States leads with 7,256 documents, followed by China with 2,518, the United Kingdom with 2,265 and Germany with 1,957. These country figures describe document activity in the available data. They do not indicate that research or commercialization is limited to these locations; organizations in many other countries are also active.
What are the applications of organ-on-a-chip?
Applications include precision medicine, drug discovery and development, disease modeling, safety and toxicity testing, and chemical and cosmetic safety. Precision medicine has 1,345 associated documents, while drug discovery and development has 775. These models let researchers investigate tissue responses and disease processes in controlled, human-relevant microenvironments.